scholarly journals Contextual risk and psychosocial profiles of opioid-using mothers: A mixed-methods study

2021 ◽  
Vol 17 ◽  
pp. 174550652110606
Author(s):  
Karina Beltrán-Arzate ◽  
Kevin Hodson ◽  
Haley K Tes ◽  
Sarah-Anne H Bowyer ◽  
Hollis C Ratliff ◽  
...  

Introduction: There is an increase in cases of mothers using opioids during pregnancy in the United States but research investigating mothers’ psychosocial environments along with individual variability among this high-risk group of women is scarce. Methods: This mixed-methods study aims to examine the complex interplay of contextual risks and experiences of opioid-using mothers. A sample of 50 opioid-using biological mothers of infants diagnosed with neonatal opioid withdrawal syndrome (NOWS) were studied using a set of standardized and open-ended questions, along with medical records extraction. Results: A high-risk subgroup of 36 mothers was identified using cluster analysis, characterized by a distinct profile of psychosocial risk. Thematic content analysis revealed four themes: (1) barriers to communication and mistrust of health professionals, (2) limitations of access to health care and the amplification of disadvantages related to COVID-19, (3) lifelong consequences of adverse childhood experiences (ACEs), and (4) intimate partner violence and its influence on drug use. Conclusion: Our findings highlight important information toward health services provision for opioid-using women of childbearing age. Efforts to reduce opioid usage in mothers need to consider psychosocial and contextual risks.

2021 ◽  
Author(s):  
Renato Andre Errea ◽  
Patricia Janet García ◽  
Lydia E. Pace ◽  
Jerome Timothy Galea ◽  
Molly Forrest Franke

2020 ◽  
pp. 088626052096713
Author(s):  
Laura A. Voith ◽  
Hyunjune Lee ◽  
Katie Russell

Despite decades of research and significant efforts by practitioners and advocates, intimate partner violence (IPV) in the United States remains a public health issue that disproportionately affects racial/ethnic minorities. The lack of mixed methods and qualitative studies, particularly with Black, Indigenous, Men of Color (BIMOC), limits the field’s ability to tease apart the complex, multifaceted aspects of IPV perpetration and minimizes diverse perspectives of how childhood trauma and key proximal factors culminate in IPV perpetration. An explanatory design, follow-up explanations model, was used with a sample of predominately low-income BIMOC in a batterer intervention program (BIP). Associations between IPV and theoretically supported factors (e.g., trauma symptoms, depression, gender roles) were examined using a cross-sectional survey ( N = 67) with ordinary least squares regression. Following up, processes explaining how these factors might lead to IPV perpetration were explored using semistructured interviews ( N = 11) with narrative analysis. Results indicate that depressive and posttraumatic stress disorder (PTSD) symptoms together predict men’s IPV perpetration. Participants’ collective narrative explains how key factors—such as adverse childhood experiences, PTSD, depression, social isolation, anger, and restricted emotionality—work together to culminate in IPV perpetration. Findings shed light on potential trajectories and antecedents that manifest in IPV perpetration, providing implications for practice techniques and program development with low-income BIMOC in BIPs.


2017 ◽  
Vol 12 (3) ◽  
pp. 199-223 ◽  
Author(s):  
Jill Theresa Messing ◽  
Sujey Vega ◽  
Alesha Durfee

This mixed-methods study examines the impact of immigration status on the ability of Latina survivors of intimate partner violence (IPV) to file for and obtain a domestic violence protection order. Undocumented Latinas living in shelters are less likely to know what a protection order is or how to obtain one. At the same time, undocumented Latinas are more likely to believe that their partner would follow an order and that police would arrest their partner for a violation. Latina survivors of IPV live at the nexus of multiple systems of oppression; therefore, understanding their experiences using an intersectional framework is critically important.


2021 ◽  
Author(s):  
Ekaterina Burduli ◽  
Hendrée E Jones ◽  
Olivia Brooks ◽  
Celestina Barbosa-Leiker ◽  
Ron Kim Johnson ◽  
...  

BACKGROUND The United States continues to experience an alarming rise in opioid use that includes women who become pregnant and related neonatal abstinence syndrome (NAS) in newborns. Most newborns experiencing NAS require nonpharmacological care, which entails, most importantly, maternal involvement with the newborn. To facilitate positive maternal-newborn interactions, mothers need to learn effective caregiving NAS strategies when they are pregnant; however, an enormous gap exists in the early education of mothers on the symptoms and progression of NAS, partly because no education, training, or other interventions exist to prepare future mothers for the challenges of caring for their newborns at risk for NAS. OBJECTIVE In this paper, we describe a mixed methods, multistage study to adapt an existing mobile NAS tool for high-risk pregnant women and assess its usability, acceptability, and feasibility in a small randomized controlled trial. METHODS Stage 1 will include 20 semistructured interviews with a panel of neonatology experts, NAS care providers, and mothers with experience caring for NAS-affected newborns to gather their recommendations on the management of NAS and explore their perspectives on the care of these newborns. The findings will guide the adaptation of existing mobile NAS tools for high-risk pregnant women. In stage 2, we will test the usability, acceptability, and feasibility of the adapted mobile tool via surveys with 10 pregnant women receiving opioid agonist therapy (OAT). Finally, in stage 3, we will randomize 30 high-risk pregnant women receiving OAT to either receive the adapted mobile NAS caregiving tool or usual care. We will compare these women on primary outcomes—maternal drug relapse and OAT continuation—and secondary outcomes—maternal-newborn bonding; length of newborn hospital stays; readmission rates; breastfeeding initiation and duration; and postpartum depression and anxiety at 4, 8, and 12 weeks postpartum. RESULTS This project was funded in July 2020 and approved by the institutional review board in April 2020. Data collection for stage 1 began in December 2020, and as of January 2021, we completed 18 semistructured interviews (10 with NAS providers and 8 with perinatal women receiving OAT). Common themes from all interviews will be analyzed in spring 2021 to inform the adaptation of the NAS caregiving tool. The results from stage 1 are expected to be published in summer 2021. Stage 2 data collection will commence in fall 2021. CONCLUSIONS The findings of this study have the potential to improve NAS care and maternal-newborn outcomes and lead to commercialized product development. If effective, our new tool will be well suited to tailoring for other high-risk perinatal women with substance use disorders. CLINICALTRIAL ClinicalTrials.gov NCT04783558; https://clinicaltrials.gov/ct2/show/NCT04783558 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/27382


Sign in / Sign up

Export Citation Format

Share Document